0001415889-24-005088.txt : 20240223 0001415889-24-005088.hdr.sgml : 20240223 20240223172737 ACCESSION NUMBER: 0001415889-24-005088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ford Robert B CENTRAL INDEX KEY: 0001612571 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 24672753 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064-6092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 form4-02232024_100230.xml X0508 4 2024-02-21 0000001800 ABBOTT LABORATORIES ABT 0001612571 Ford Robert B 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064 true true false false CHAIRMAN AND CEO 0 Common shares without par value 2024-02-21 4 A 0 70332 0 A 251669 D Common shares without par value 197403 I Ford Family Trust Option (right to buy) 116.98 2024-02-21 4 A 0 264293 0 A 2025-02-21 2034-02-20 Common Shares 264293 264293 D These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes. Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 88,097 on February 21, 2025, 88,098 on February 21, 2026, and 88,098 on February 21, 2027. /s/ Robert B. Ford by Jessica H. Paik, Attorney-in-Fact 2024-02-23